Novartis AGNVSNYSE

Revenue (LTM)

$54.8B

+6.0% YoY

Net Income (LTM)

$14.1B

+17.7% YoY

Free Cash Flow

$17.7B

Revenue CAGR (5Y)

+1.9%

—Marginsstable

FCF$17.7B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	43,974	43,461↓1.2%	46,660↑7.4%	51,722↑10.8%	54,811↑6.0%
Gross Profit	32,239	31,879↓1.1%	34,188↑7.2%	38,895↑13.8%	41,122↑5.7%
Operating Income	10,056	7,946↓21.0%	9,769↑22.9%	14,544↑48.9%	17,074↑17.4%
Net Income	24,021	6,955↓71.0%	14,850↑113.5%	11,941↓19.6%	14,056↑17.7%
EBITDA	30,914	14,682↓52.5%	18,255↑24.3%	20,715↑13.5%	22,987↑11.0%
EPS Diluted	10.63	3.17↓70.2%	7.10↑124.0%	5.87↓17.3%	7.19↑22.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	12,407	7,517↓39.4%	13,393↑78.2%	11,459↓14.4%	11,435↓0.2%
Total Current Assets	45,718	36,910↓19.3%	30,481↓17.4%	29,704↓2.5%	30,460↑2.5%
Total Assets	131,795	117,453↓10.9%	99,945↓14.9%	102,246↑2.3%	115,569↑13.0%
Total Current Liabilities	30,208	28,656↓5.1%	26,390↓7.9%	28,692↑8.7%	27,278↓4.9%
Total Liabilities	63,973	58,030↓9.3%	53,195↓8.3%	58,120↑9.3%	69,020↑18.8%
Total Equity	67,655	59,342↓12.3%	46,667↓21.4%	44,046↓5.6%	46,130↑4.7%
Total Debt	31,025	27,909↓10.0%	26,348↓5.6%	31,258↑18.6%	37,033↑18.5%
Net Debt	18,618	20,392↑9.5%	12,955↓36.5%	19,799↑52.8%	25,598↑29.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	15,071	14,236↓5.5%	14,458↑1.6%	17,619↑21.9%	19,242↑9.2%
Capital Expenditure	-2,556	-2,239↑12.4%	-2,753↓23.0%	-3,814↓38.5%	-1,556↑59.2%
Free Cash Flow	12,515	11,997↓4.1%	11,705↓2.4%	13,805↑17.9%	17,686↑28.1%
Stock-Based Comp	700	791↑13.0%	865↑9.4%	1,044↑20.7%	0
Net Change in Cash	2,749	-4,890↓277.9%	5,876↑220.2%	-1,934↓132.9%	-24↑98.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance